首页> 中文期刊> 《肿瘤基础与临床》 >三维适形放疗联合周剂量奈达铂治疗老年非小细胞肺癌的临床观察

三维适形放疗联合周剂量奈达铂治疗老年非小细胞肺癌的临床观察

         

摘要

目的:探讨三维适形放疗联合周剂量奈达铂治疗老年非小细胞肺癌( NSCLC)的疗效及毒副反应。方法选择63例老年NSCLC患者,随机分为2组,其中观察组31例,对照组32例,均予三维适形放疗,观察组同步进行周剂量奈达铂化疗。结果观察组、对照组疾病控制率分别为80.6%和68.6%;1 a生存率分别为77.4%和68.8%。2组主要毒副反应为急性放射性肺炎、支气管炎,急性放射性食管炎,骨髓抑制等。结论三维适形放疗联合周剂量奈达铂治疗老年NSCLC疗效较好,毒副反应可耐受。%Objective To investigate the efficacy and toxicities of three dimensional-conformal radiotherapy com-bined with weekly low-dose nedaplatin for elderly patients with advanced non-small cell lung cancer( NSCLC ). Methods Sixty-three elderly patients with advanced NSCLC were randomly divided into two groups(31 patients of the observation group and 32 patients of the control group),and were given with three dimensional-conformal radio-therapy,31 patients of the observation group were given with weekly low-dose nedaplatin. Results The disease con-trol rate was 80. 6% of the observation group,and was 68. 6% of the control group;1-year survival rates were 77. 4% and 68. 8%,respectively. The main toxicities were acute radiation-related pneumonia and bronchitis,acute radiation-related esophagitis,and marrow suppression. Conclusion Three dimensional-conformal radiotherapy com-bined with weekly low-dose nedaplatin is effect and well tolerated for elderly patients with advanced NSCLC.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号